Because of the insufficient data for other clinicopathological parameters (such as tumor location, family history of cancer, alcohol consumption), the relationship between increased SPRY4-IT1 expression level and these clinicopathological parameters were not processed for the meta-analysis. The gene discussed is SPRY4; the disease is cancer.